Helmut Albrecht - Concepedia

Author

Helmut Albrecht

Also Known As

Albrecht H., Albrecht, Helmut, Carlos del Rio, Charles B Hicks, H ALBRECHT, H Albrecht, H. A. Albrecht, H. ALBRECHT, H. Albrecht, Helen Albrecht

311

Publications

4.6K

Citations

H-Index

Concepts

All Affiliations

University of South Carolina Eppendorf (Germany)Palmetto Health Richland Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Helmut Albrecht is an author at University of South Carolina specializing in medicine, hiv, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	35	1.7K
2	Public Health	5	5	204
3	Health Sciences	2	2	63
4	Engineering	1	1	58
5	Social Sciences	1	1	12

Helmut Albrecht

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial François Raffi, Hans Jaeger, Eugenia Quirós-Roldán, The Lancet Infectious Diseases Treatment And PreventionHuman RetrovirusClinical TrialsAntiviral TherapyHiv-1 Infection	2013	370
Loss of CD127 Expression Defines an Expansion of Effector CD8+ T Cells in HIV-Infected Individuals Mirko Paiardini, Barbara Cervasi, Helmut Albrecht, The Journal of Immunology	2005	228
Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner Rajeev Mehla, Shalmali Bivalkar-Mehla, Ruonan Zhang, PLoS ONE	2010	221
Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy Helmut Albrecht, Christian Hoffmann, Olaf Degen, AIDS	1998	150
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial Hans‐Jürgen Stellbrink, José Ramón Arribas, Jeffrey L. Stephens, The Lancet HIV Week 96Antiviral Drug DevelopmentAntiviral TherapyVirologyPharmacotherapy	2019	141
CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection Richard M. Dunham, Barbara Cervasi, Jason M. Brenchley, The Journal of Immunology	2008	121
Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections P. Brandon Bookstaver, Elizabeth Nimmich, T. J. Smith, Antimicrobial Agents and Chemotherapy	2017	94
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections Leila F. Kutob, Julie Ann Justo, P. Brandon Bookstaver, International Journal of Antimicrobial Agents Definitive TherapyAntimicrobial SusceptibilityAntibioticsAntimicrobial TherapyAntimicrobial Chemotherapy	2016	85
Stratification of the Impact of Inappropriate Empirical Antimicrobial Therapy for Gram-Negative Bloodstream Infections by Predicted Prognosis Sarah Cain, Joseph Kohn, P. Brandon Bookstaver, Antimicrobial Agents and Chemotherapy Bsimrs CategoryLogistic AnalysisAntimicrobial StewardshipHealthcare-associated InfectionClinical Epidemiology	2014	82
Bacillary Angiomatosis in HIV-Infected Patients – An Epidemiological and Clinical Study Andreas Plettenberg, Thore Lorenzen, B.T. Burtsche, Dermatology	2000	77

Page 1